-transparent.png){kind=logo}
CCR3 is expressed in a variety of leukocyte subsets, especially eosinophils, and may be involved in allergic disorders such as atopic asthma. To clarify the pathophysiological roles of CCR3 in allergic disorders, we developed a nonpeptidyl CCR3 antagonist. This antagonist, which is referred to as "Compound X," that inhibited the binding of [(125)I]Eotaxin to CHO cells transfected with human CCR3 with an IC(50) value of 2.3 nM. In human eosinophils, Compound X also inhibited Eotaxin-induced increases in intracellular Ca(2+) concentrations and chemotaxis. Thus, Compound X appears to be a highly potent CCR3 antagonist. These findings suggest that Compound X may be a useful tool for elucidating the pathophysiological roles of CCR3 in a variety of allergic disorders.
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
January 1993,
The Journal of pharmacology and experimental therapeutics,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
December 1995,
The Journal of pharmacology and experimental therapeutics,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
March 2001,
Journal of medicinal chemistry,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
January 2000,
European journal of pharmacology,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
August 2000,
The Journal of biological chemistry,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
January 1996,
Life sciences,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
July 1998,
Bioorganic & medicinal chemistry letters,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
November 2005,
Bioorganic & medicinal chemistry letters,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
January 2007,
Journal of medicinal chemistry,
T Saeki, and
K Ohwaki, and
A Naya, and
K Kobayashi, and
M Ishikawa, and
N Ohtake, and
K Noguchi
March 2021,
Cell & bioscience,
